151 related articles for article (PubMed ID: 29446856)
21. CDX2 expression in columnar cell variant of papillary thyroid carcinoma.
Enriquez ML; Baloch ZW; Montone KT; Zhang PJ; LiVolsi VA
Am J Clin Pathol; 2012 May; 137(5):722-6. PubMed ID: 22523209
[TBL] [Abstract][Full Text] [Related]
22. Follicular variant papillary thyroid carcinoma in a pediatric population.
Lerner J; Goldfarb M
Pediatr Blood Cancer; 2015 Nov; 62(11):1942-6. PubMed ID: 26131690
[TBL] [Abstract][Full Text] [Related]
23. High recurrent rate of multicentric papillary thyroid carcinoma.
Lin JD; Chao TC; Hsueh C; Kuo SF
Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
[TBL] [Abstract][Full Text] [Related]
24. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: Can Cytology Face the Challenge of Diagnosis in the Light of the New Classification?
Díaz Del Arco C; Fernández Aceñero MJ
Acta Cytol; 2018; 62(4):265-272. PubMed ID: 29860249
[TBL] [Abstract][Full Text] [Related]
25. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
Rossi ED; Martini M; Bizzarro T; Capodimonti S; Cenci T; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM
Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187
[TBL] [Abstract][Full Text] [Related]
26. Encapsulated follicular variant of papillary thyroid carcinoma/noninvasive follicular thyroid neoplasm with papillary-like nuclear features with Spindle Cell Metaplasia: Case report and review of literature.
Haroon Al Rasheed MR; Acosta A; Tarjan G
Pathol Res Pract; 2017 Apr; 213(4):416-421. PubMed ID: 28216141
[TBL] [Abstract][Full Text] [Related]
27. Significance of tumor capsular invasion in well-differentiated thyroid carcinomas.
Furlan JC; Bedard YC; Rosen IB
Am Surg; 2007 May; 73(5):484-91. PubMed ID: 17521005
[TBL] [Abstract][Full Text] [Related]
28. [The value of quantitative DNA analysis in evaluating the prognosis of differentiated thyroid cancer].
Böttger T; Potratz D; Schernus B; Klupp J; Stöckle M; Junginger T
Chirurg; 1994 Mar; 65(3):190-3. PubMed ID: 8194403
[TBL] [Abstract][Full Text] [Related]
29. [Follicular cell (papillary and follicular) thyroid carcinoma, genetic inheritance, and molecular diagnostic markers].
Kazubskaia TP; Kozlova VM; Kondrat'eva TT; Pavlovskaia AI; Marakhonov AV; Baranova AV; Ivanova NI; Stepanova AA; Poliakov AV; Belev NF; Brzhezovskiĭ VZh
Arkh Patol; 2014; 76(5):3-12. PubMed ID: 25543402
[TBL] [Abstract][Full Text] [Related]
30. Columnar cell variant of papillary thyroid carcinoma: Cytomorphological characteristics of 11 cases with histological correlation and literature review.
Bongiovanni M; Mermod M; Canberk S; Saglietti C; Sykiotis GP; Pusztaszeri M; Ragazzi M; Mazzucchelli L; Giovanella L; Piana S
Cancer Cytopathol; 2017 Jun; 125(6):389-397. PubMed ID: 28374549
[TBL] [Abstract][Full Text] [Related]
31. Aggressive Variants of Papillary Thyroid Carcinoma: Hobnail, Tall Cell, Columnar, and Solid.
Nath MC; Erickson LA
Adv Anat Pathol; 2018 May; 25(3):172-179. PubMed ID: 29351089
[TBL] [Abstract][Full Text] [Related]
32. Insular carcinomas of the thyroid exhibit poor prognosis and long-term survival in comparison to follicular and papillary T4 carcinomas.
Agha A; Glockzin G; Woenckhaus M; Dietmaier W; Iesalnieks I; Schlitt HJ
Langenbecks Arch Surg; 2007 Nov; 392(6):671-7. PubMed ID: 17216284
[TBL] [Abstract][Full Text] [Related]
33. Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma.
Zhao L; Dias-Santagata D; Sadow PM; Faquin WC
Cancer Cytopathol; 2017 May; 125(5):323-331. PubMed ID: 28192645
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological roles of alterations of tumor suppressor gene p16 in papillary thyroid carcinoma.
Lam AK; Lo CY; Leung P; Lang BH; Chan WF; Luk JM
Ann Surg Oncol; 2007 May; 14(5):1772-9. PubMed ID: 17195959
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathologic evaluation of immunohistochemical CD147 and MMP-2 expression in differentiated thyroid carcinoma.
Tan H; Ye K; Wang Z; Tang H
Jpn J Clin Oncol; 2008 Aug; 38(8):528-33. PubMed ID: 18664479
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic significance of CK19, RET, galectin-3 and HBME-1 expression for papillary thyroid carcinoma.
Zhu X; Sun T; Lu H; Zhou X; Lu Y; Cai X; Zhu X
J Clin Pathol; 2010 Sep; 63(9):786-9. PubMed ID: 20644217
[TBL] [Abstract][Full Text] [Related]
37. [Problems in pathologic diagnosis of thyroid follicular cell carcinoma].
Li Y; Huo Z; Chen J
Zhonghua Bing Li Xue Za Zhi; 2014 May; 43(5):348-52. PubMed ID: 25030874
[No Abstract] [Full Text] [Related]
38. [Pathologic study of expression and significance of matrix metalloproteinases-9, tissue inhibitor of metalloproteinase-1, vascular endothelial growth factor and transforming growth factor beta-1 in papillary carcinoma and follicular carcinoma of thyroid].
Wang T; Jiang CX; Li Y; Liu X
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):824-8. PubMed ID: 20193458
[TBL] [Abstract][Full Text] [Related]
39. Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases.
Asioli S; Erickson LA; Sebo TJ; Zhang J; Jin L; Thompson GB; Lloyd RV
Am J Surg Pathol; 2010 Jan; 34(1):44-52. PubMed ID: 19956062
[TBL] [Abstract][Full Text] [Related]
40. Early recurrence of papillary and follicular thyroid carcinoma predicts a worse outcome.
Lin JD; Hsueh C; Chao TC
Thyroid; 2009 Oct; 19(10):1053-9. PubMed ID: 19772423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
